Your browser doesn't support javascript.
loading
Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies.
Dubois, Sigrid P; Miljkovic, Milos D; Fleisher, Thomas A; Pittaluga, Stefania; Hsu-Albert, Jennifer; Bryant, Bonita R; Petrus, Michael N; Perera, Liyanage P; Müller, Jürgen R; Shih, Joanna H; Waldmann, Thomas A; Conlon, Kevin C.
Afiliación
  • Dubois SP; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Miljkovic MD; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Fleisher TA; Department of Laboratory Medicine, NIH Clinical Center, Bethesda, Maryland, USA.
  • Pittaluga S; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Hsu-Albert J; Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Bryant BR; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Petrus MN; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Perera LP; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Müller JR; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Shih JH; Biometric Research Program, Division of Cancer Treatment and Diagnosis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Waldmann TA; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA tawald@mail.nih.gov.
  • Conlon KC; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
J Immunother Cancer ; 9(4)2021 04.
Article en En | MEDLINE | ID: mdl-33883258
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Activación de Linfocitos / Interleucina-15 / Proliferación Celular / Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Activación de Linfocitos / Interleucina-15 / Proliferación Celular / Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido